NeuroMetrix Inc (NURO)
4.30
-0.17
(-3.80%)
USD |
NASDAQ |
May 03, 16:00
4.35
+0.05
(+1.16%)
After-Hours: 20:00
NeuroMetrix Cash from Financing (Quarterly): 1.624M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.624M |
| September 30, 2023 | 0.0014M |
| June 30, 2023 | 0.7001M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 1.913M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0078M |
| March 31, 2022 | 1.943M |
| December 31, 2021 | -0.1223M |
| September 30, 2021 | 15.88M |
| June 30, 2021 | 3.816M |
| March 31, 2021 | -0.0258M |
| December 31, 2020 | 0.0158M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 3.698M |
| March 31, 2020 | 0.4535M |
| December 31, 2019 | 0.0076M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0075M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0094M |
| September 30, 2018 | 0.0093M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 3.340M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.257M |
| June 30, 2017 | 0.0104M |
| March 31, 2017 | 6.302M |
| December 31, 2016 | 0.0167M |
| September 30, 2016 | -0.069M |
| June 30, 2016 | 6.796M |
| March 31, 2016 | -0.0767M |
| December 31, 2015 | 6.825M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 10.11M |
| March 31, 2015 | |
| December 31, 2014 | 0.0139M |
| September 30, 2014 | -0.0421M |
| June 30, 2014 | 7.960M |
| March 31, 2014 | |
| December 31, 2013 | 2.642M |
| September 30, 2013 | -0.0711M |
| June 30, 2013 | 4.571M |
| March 31, 2013 | -0.0053M |
| December 31, 2012 | 0.0063M |
| September 30, 2012 | -0.0051M |
| June 30, 2012 | -0.071M |
| March 31, 2012 | 7.532M |
| December 31, 2011 | 0.0132M |
| September 30, 2011 | -0.0032M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1223M
Minimum
Dec 2021
15.88M
Maximum
Sep 2021
1.575M
Average
0.0078M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Teleflex Inc | -71.45M |
| Perspective Therapeutics Inc | 0.352M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.450M |
| Cash from Investing (Quarterly) | 0.098M |
| Free Cash Flow | -6.268M |
| Free Cash Flow Per Share (Quarterly) | -1.295 |
| Free Cash Flow to Equity (Quarterly) | -1.496M |
| Free Cash Flow Yield | -139.9% |